Table 1 Obstetrical Outcomes
| Â | Misoprostol n = 80 (%) | Dinoprostone n = 83 (%) | Statistical significance |
|---|---|---|---|
Time from induction to delivery (h ± SEM) | 11.9 ± 0.6 | 15.6 ± 0.7 | p < 0.001 |
Delivery < 12 h | 46 (57.5%) | 27 (32.5%) | p < 0.01 |
Delivery < 24 h | 79 (98.8%) | 76 (91.6%) | p < 0.05 |
Number of doses | Â | Â | Â |
   Single dose | 74 (92.4%) | 65 (78.3%) | p < 0.05 |
   Second dose | 6 (7.5%) | 17 (20.5%) |  |
   Third dose | 0 (0%) | 1 (1.2%) |  |
Required oxytocin augmentation | 53(65.8%) | 67(80.7%) | p < 0.05 |
Spontaneous rupture of membranes | 31 (38.8%) | 17 (20.5%) | p < 0.05 |
Meconium stained AF | 15 (18.8%) | 7 (9.6%) | NS |
Abnormal FHR | 18 (22.5%) | 10 (12%) | NS |
Uterine Tachysystole | 10 (12.6%) | 3 (3.6%) | p < 0.05 |
Uterine Hyperstimulation | 2 (2.5%) | 1 (1.2%) | NS |